1. Home
  2. XYF vs TNXP Comparison

XYF vs TNXP Comparison

Compare XYF & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo X Financial each representing six

XYF

X Financial each representing six

HOLD

Current Price

$4.78

Market Cap

186.4M

Sector

Finance

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$11.57

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XYF
TNXP
Founded
2014
2007
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.4M
199.7M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
XYF
TNXP
Price
$4.78
$11.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
55.3K
529.4K
Earning Date
05-18-2026
05-11-2026
Dividend Yield
11.34%
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
N/A
$558.11
Revenue Next Year
N/A
$38.29
P/E Ratio
$0.90
N/A
Revenue Growth
N/A
29.85
52 Week Low
$3.30
$10.03
52 Week High
$18.98
$69.65

Technical Indicators

Market Signals
Indicator
XYF
TNXP
Relative Strength Index (RSI) 49.28 43.46
Support Level $4.54 $10.03
Resistance Level $5.15 $13.18
Average True Range (ATR) 0.21 0.86
MACD -0.02 -0.10
Stochastic Oscillator 36.21 26.98

Price Performance

Historical Comparison
XYF
TNXP

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: